Diphtheria is a serious infectious disease caused by the bacteriumCorynebacterium diphtheriae, and the primary factor responsible for its harmful effects is the diphtheria toxin. This potent protein toxin interferes with essential cellular processes and can lead to cell death, tissue damage, and systemic complications in infected individuals. Understanding the mechanism of action of diphtheria toxin is crucial for medical science, as it provides insight into bacterial pathogenesis, cellular biology, and strategies for treatment and prevention. The toxin’s action is highly specific and involves a series of steps including binding, internalization, enzymatic activity, and inhibition of protein synthesis, all of which contribute to its deadly effects.
Structure of Diphtheria Toxin
Diphtheria toxin is a single-chain polypeptide composed of 535 amino acids and has a molecular weight of approximately 58 kDa. It is composed of two main functional domains
- Fragment B (Binding domain)This domain allows the toxin to bind to the host cell surface receptor, ensuring specificity for susceptible cells.
- Fragment A (Active domain)This domain possesses enzymatic activity and is responsible for the inhibition of protein synthesis once inside the host cell.
The toxin is initially secreted as a single polypeptide and later undergoes proteolytic cleavage to activate its cytotoxic function while remaining connected by a disulfide bond. This structure is critical for the proper delivery and function of the toxin in target cells.
Binding to Host Cells
The first step in the mechanism of diphtheria toxin is its attachment to host cells. Fragment B specifically binds to a cell surface receptor known as the heparin-binding epidermal growth factor-like precursor (HB-EGF) receptor. This receptor is widely expressed on epithelial cells and heart tissue, explaining why the respiratory tract and cardiac tissue are particularly affected during infection. The binding step is highly specific, which allows the toxin to selectively enter susceptible cells while sparing others.
Receptor-Mediated Endocytosis
Once diphtheria toxin binds to the HB-EGF receptor, it is internalized by the host cell through receptor-mediated endocytosis. During this process, the plasma membrane invaginates to form an endocytic vesicle that encloses the toxin-receptor complex. The vesicle then undergoes acidification, which triggers conformational changes in the toxin necessary for the next stage of its action. This endocytic uptake is a critical step, as it delivers the toxin safely into the host cell cytoplasm without degradation by extracellular enzymes.
Translocation into the Cytoplasm
Inside the acidified endocytic vesicle, the diphtheria toxin undergoes a structural change that allows fragment A to translocate into the cytoplasm. Fragment B facilitates this process by forming a channel in the endosomal membrane. The acidic environment of the vesicle protonates specific amino acids, causing fragment A to unfold and pass through the channel. Once in the cytoplasm, the disulfide bond linking fragments A and B is reduced, releasing the enzymatically active fragment A to exert its cytotoxic effects. This translocation step ensures that fragment A reaches the cytoplasm intact, where it can target essential cellular machinery.
Inhibition of Protein Synthesis
The primary cytotoxic action of diphtheria toxin occurs through fragment A’s enzymatic activity. Fragment A acts as an ADP-ribosyltransferase, which transfers an ADP-ribose moiety from nicotinamide adenine dinucleotide (NAD⁺) to elongation factor 2 (EF-2), a critical protein in the host cell’s protein synthesis machinery. EF-2 is necessary for the translocation step during translation, and its inactivation prevents ribosomes from producing new proteins. Without protein synthesis, cells are unable to maintain essential functions, leading to cell death.
Specificity for Eukaryotic Cells
The enzymatic activity of fragment A is highly specific for eukaryotic EF-2 due to the presence of a unique post-translational modification called diphthamide. This modification occurs in histidine residues of EF-2 and is the specific target of ADP-ribosylation by diphtheria toxin. Bacterial EF-2 lacks diphthamide, explaining why the toxin does not affect the bacteria that produce it. This specificity underlies the high potency of the toxin in human cells while sparing the pathogen itself.
Cellular Consequences of Diphtheria Toxin Action
The inhibition of protein synthesis by diphtheria toxin leads to several cellular and systemic effects. At the cellular level, the lack of protein production triggers cell death, which can manifest as necrosis or apoptosis. Tissues exposed to the toxin, such as respiratory epithelium and cardiac tissue, are particularly vulnerable. Systemically, the toxin can enter the bloodstream, leading to widespread organ damage. Complications include myocarditis, neuropathy, and kidney damage. These effects highlight the importance of early detection and treatment to prevent severe outcomes.
Immune Response and Toxin Neutralization
The human immune system can recognize and neutralize diphtheria toxin through the production of specific antibodies. Vaccination with diphtheria toxoid, an inactivated form of the toxin, stimulates the immune system to produce antibodies that bind the toxin and prevent it from interacting with host cells. This immune response is highly effective in preventing the disease and is the basis for the diphtheria vaccine included in childhood immunization programs. Without vaccination, individuals remain highly susceptible to the lethal effects of the toxin.
Clinical Implications and Therapeutic Interventions
Understanding the mechanism of action of diphtheria toxin has direct clinical relevance. In cases of diphtheria infection, treatment involves the administration of diphtheria antitoxin, which neutralizes circulating toxin and prevents it from entering cells. Antibiotics are also used to eliminate the bacterial infection, reducing further toxin production. Early intervention is crucial because once fragment A enters the cytoplasm and inhibits protein synthesis, cell damage may become irreversible. Research on toxin inhibitors, recombinant antibodies, and other molecular interventions continues to improve therapeutic options.
Summary of Mechanistic Steps
- Binding Fragment B binds to the HB-EGF receptor on host cells.
- Endocytosis The toxin-receptor complex is internalized into endocytic vesicles.
- Translocation Acidification triggers fragment A to translocate into the cytoplasm.
- Disulfide Reduction Fragment A is released from fragment B.
- Enzymatic Action Fragment A ADP-ribosylates EF-2, inhibiting protein synthesis.
- Cell Death Inhibition of protein synthesis leads to apoptosis or necrosis.
The diphtheria toxin is a highly potent bacterial exotoxin that exerts its effects through a carefully orchestrated mechanism of binding, internalization, translocation, and enzymatic inhibition of protein synthesis. By targeting elongation factor 2, the toxin effectively shuts down essential cellular functions, leading to cell death and severe tissue damage. Understanding this mechanism has informed both preventive and therapeutic strategies, including vaccination and antitoxin administration, which remain critical tools in controlling diphtheria. Studying the action of diphtheria toxin also provides broader insights into bacterial pathogenesis, host-pathogen interactions, and the molecular biology of protein synthesis inhibition, highlighting the importance of biochemical research in combating infectious diseases.